JAGUAR HEALTH Revenue, Profits - JAGX Quarterly Income Statement

Add to My Stocks
$0.56 $0.01 (1.82%) JAGX stock closing price Sep 18, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the JAGUAR HEALTH stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. Like any other income statement, the JAGX income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue decline of 0 when compared to the same period in the past. Along with JAGUAR HEALTH assets and JAGUAR HEALTH free cash flow, JAGUAR HEALTH profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q2 is $-7.66M and the 2018 Q2 revenue is $-.

View and download details of revenue and profits for JAGUAR HEALTH for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
JAGUAR HEALTH Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Research & Development Expense1.6M-1.24M--1.25M1.54M1.96M1.95M1.75M
Selling General & Admin Expense5.75M4.71M4.89M3.73M2.29M3.42M1.79M1.25M1.47M1.95M
Income Before Depreciation Depletion Amortization-7.08M-5.12M-5.21M-3.69M-2.35M-3.87M-3.33M-3.17M-3.4M-3.68M
Depreciation Depletion Amortization--15.48M3.64M------
Non Operating Income---0.12M---0.65M-0.15M---0.01M
Interest Expense----------
Provision for Income Taxes---0.99M-12.19M------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-7.66M-5.7M-20.2M4.76M-1.81M-4.72M-3.68M-3.42M-3.66M-3.98M
Extraordinary Items & Discontinued Operations----------
JAGUAR HEALTH Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS-8.64M-4.48M------
Average Shares used to compute Basic EPS-8.64M-3.7M------
Income Before Nonrecurring Items--5.43M-8.8M-1.81M-4.05M-3.68M-3.42M-3.66M-3.98M
Income from Nonrecurring Items--0.26M--4.04M--0.66M----
JAGUAR HEALTH Earnings Per Share Basic Net
JAGUAR HEALTH Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items--0.75-1.95-1.80-4.20-4.20-4.50-5.25-6.45
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on JAGUAR HEALTH stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: JAGUAR HEALTH revenue chart, implies that the company is growing. It has not been the case with JAGUAR HEALTH. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. JAGX stock had a poor bottom line growth.

The income statement is also called statement of revenue and expense. The JAGX financials along with JAGUAR HEALTH historical stock prices provide a lot of details about the firm.

JAGUAR HEALTH Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield